LPCUF (Lee's Pharmaceutical Holdings) YoY Rev. per Sh. Growth : 28.83% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Lee's Pharmaceutical Holdings's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 was 28.83%.

Lee's Pharmaceutical Holdings's Revenue per Share for the six months ended in Jun. 2024 was $0.14.

Lee's Pharmaceutical Holdings YoY Rev. per Sh. Growth Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings YoY Rev. per Sh. Growth Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

1.14

3.37

-2.54

-14.87

33.62

Lee's Pharmaceutical Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-14.19	-20.71	-7.09	28.83	37.29

Lee's Pharmaceutical Holdings YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Lee's Pharmaceutical Holdings's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.229	-	0.269)	/	\| 0.269 \|
=	-14.87 %

Lee's Pharmaceutical Holdings's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Jun. 2024 )
=	(Revenue per Share (Q: Jun. 2024 )	-	Revenue per Share (Q: Jun. 2023 ))	/	\| Revenue per Share (Q: Jun. 2023 )) \|
=	(0.143	-	0.111)	/	\| 0.111 \|
=	28.83 %

Lee's Pharmaceutical Holdings YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » YoY Rev. per Sh. Growth

Traded in Other Exchanges

00950:Hong Kong

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines